Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT

Nektar Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.61 -0.39 -1.15 -4.73
PEG Ratio
0.03 0.01 0.04 -0.32
PS Ratio
1.94 1.19 4.59 24.30
PB Ratio
3.15 0.82 1.15 3.64
P/FCF Ratio
-1.08 -0.56 -1.37 -5.79
P/OCF Ratio
-1.09 -0.56 -1.39 -6
OCF/S Ratio
-1.79 -2.14 -3.3 -4.05
Debt / Equity Ratio
1.69 0.90 0.36 0.21
Quick Ratio
4.26 6.14 7.72 9.15
Current Ratio
4.26 6.45 8.00 9.34
Asset Turnover
0.32 0.23 0.13 0.09
Interest Coverage
-3.74 -5.42 -8.31 -9.43
Return on Equity
-1.96 -2.11 -1 -0.77
Return on Assets
-0.39 -0.69 -0.52 -0.47
Return on Invested Capital
-0.4 -0.36 -0.36 -0.42
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.69 0.59 0.76 0.76
Net Profit Margin
-1.21 -3.06 -4 -5.14
Pretax Profit Margin
-1.21 -3.07 -3.96 -5.13
Operating Profit Margin
-1.07 -1.52 -2.61 -4.38
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.88 -2.7 -3.52 -4.54